Swiss National Bank’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.69M Sell
41,400
-400
-1% -$55K ﹤0.01% 1216
2025
Q1
$7.54M Sell
41,800
-600
-1% -$108K 0.01% 1035
2024
Q4
$6.64M Buy
42,400
+3,300
+8% +$517K ﹤0.01% 1148
2024
Q3
$7.12M Buy
39,100
+2,900
+8% +$528K ﹤0.01% 1111
2024
Q2
$6.65M Hold
36,200
﹤0.01% 1099
2024
Q1
$6.44M Buy
36,200
+300
+0.8% +$53.4K ﹤0.01% 1138
2023
Q4
$4.45M Sell
35,900
-3,500
-9% -$434K ﹤0.01% 1360
2023
Q3
$4.57M Sell
39,400
-2,700
-6% -$313K ﹤0.01% 1330
2023
Q2
$4.94M Buy
42,100
+3,200
+8% +$376K ﹤0.01% 1324
2023
Q1
$3.11M Sell
38,900
-4,500
-10% -$360K ﹤0.01% 1565
2022
Q4
$3.44M Buy
43,400
+800
+2% +$63.4K ﹤0.01% 1544
2022
Q3
$2.97M Buy
42,600
+1,400
+3% +$97.6K ﹤0.01% 1601
2022
Q2
$2.71M Hold
41,200
﹤0.01% 1705
2022
Q1
$2.74M Buy
41,200
+2,800
+7% +$186K ﹤0.01% 1847
2021
Q4
$2.69M Buy
38,400
+6,600
+21% +$462K ﹤0.01% 1862
2021
Q3
$1.66M Buy
31,800
+400
+1% +$20.9K ﹤0.01% 2166
2021
Q2
$2.14M Buy
31,400
+2,100
+7% +$143K ﹤0.01% 2056
2021
Q1
$2.26M Buy
29,300
+400
+1% +$30.8K ﹤0.01% 1926
2020
Q4
$1.73M Hold
28,900
﹤0.01% 1985
2020
Q3
$1.24M Buy
28,900
+500
+2% +$21.5K ﹤0.01% 1968
2020
Q2
$1.18M Buy
28,400
+6,600
+30% +$273K ﹤0.01% 2015
2020
Q1
$943K Buy
21,800
+300
+1% +$13K ﹤0.01% 1863
2019
Q4
$1.19M Buy
21,500
+1,000
+5% +$55.4K ﹤0.01% 2037
2019
Q3
$712K Hold
20,500
﹤0.01% 2227
2019
Q2
$826K Buy
+20,500
New +$826K ﹤0.01% 2217